MetLife Investment Management’s Acceleron Pharma Inc. XLRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-19,395
| Closed | -$1.74M | – | 2385 |
|
|
2020
Q1 | $1.74M | Hold |
19,395
| – | – | 0.02% | 664 |
|
|
2019
Q4 | $1.03M | Hold |
19,395
| – | – | 0.01% | 1089 |
|
|
2019
Q3 | $766K | Sell |
19,395
-2,252
| -10% | -$89K | 0.01% | 1186 |
|
|
2019
Q2 | $889K | Buy |
21,647
+2,339
| +12% | +$96.1K | 0.01% | 1164 |
|
|
2019
Q1 | $899K | Buy |
19,308
+1,902
| +11% | +$88.6K | 0.01% | 1124 |
|
|
2018
Q4 | $758K | Hold |
17,406
| – | – | 0.01% | 1136 |
|
|
2018
Q3 | $996K | Hold |
17,406
| – | – | 0.01% | 1122 |
|
|
2018
Q2 | $845K | Hold |
17,406
| – | – | 0.01% | 1101 |
|
|
2018
Q1 | $681K | Hold |
17,406
| – | – | 0.01% | 1192 |
|
|
2017
Q4 | $739K | Buy |
+17,406
| New | +$739K | 0.01% | 1174 |
|